KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ambev (ABEV) EBT (2016 - 2025)

Historic EBT for Ambev (ABEV) over the last 14 years, with Q3 2025 value amounting to $957.3 million.

  • Ambev's EBT rose 1368.17% to $957.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 646.39%. This contributed to the annual value of $3.4 billion for FY2024, which is 1128.41% up from last year.
  • Per Ambev's latest filing, its EBT stood at $957.3 million for Q3 2025, which was up 1368.17% from $604.0 million recorded in Q2 2025.
  • In the past 5 years, Ambev's EBT registered a high of $1.2 billion during Q4 2024, and its lowest value of $478.9 million during Q2 2023.
  • For the 5-year period, Ambev's EBT averaged around $753.2 million, with its median value being $735.8 million (2021).
  • The largest annual percentage gain for Ambev's EBT in the last 5 years was 22884.31% (2021), contrasted with its biggest fall of 5306.75% (2021).
  • Quarter analysis of 5 years shows Ambev's EBT stood at $735.8 million in 2021, then increased by 11.8% to $822.6 million in 2022, then increased by 16.07% to $954.8 million in 2023, then grew by 24.54% to $1.2 billion in 2024, then dropped by 19.49% to $957.3 million in 2025.
  • Its EBT stands at $957.3 million for Q3 2025, versus $604.0 million for Q2 2025 and $828.8 million for Q1 2025.